Expert Ratings for Pliant Therapeutics
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 16 analysts have published their opinion on Pliant Therapeutics (NASDAQ:PLRX) stock, with an average price target of $51.25, implying upside from the current price of $22.15. The current average has decreased by 2.38% from the previous average price target of $52.50.
May 18, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pliant Therapeutics (NASDAQ:PLRX) has an average price target of $51.25 from 16 analysts, implying upside from the current price of $22.15.
The average price target of $51.25 from 16 analysts implies a significant upside from the current price of $22.15. This suggests that the stock is undervalued and has potential for growth in the short term. The decrease in the average price target by 2.38% from the previous average of $52.50 may indicate a slight change in analysts' outlook, but the overall sentiment remains positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100